Regeneron Highlights Promising Ovarian Cancer, Muscle Preservation Trial Data

Regeneron Pharmaceuticals disclosed clinical trial results for two investigational therapies: one targeting recurrent ovarian cancer and another intended to prevent muscle loss during weight management. The article does not provide efficacy, safety, or financial details, limiting assessment of the programs' commercial significance.